Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -13.31
- Piotroski Score 3.00
- Grade Buy
- Symbol (EVOK)
- Company Evoke Pharma, Inc.
- Price $4.50
- Changes Percentage (-1.32%)
- Change -$0.06
- Day Low $4.50
- Day High $4.59
- Year High $17.40
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/05/2025
- Fiscal Year End N/A
- Average Stock Price Target $18.00
- High Stock Price Target $18.00
- Low Stock Price Target $18.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.83
- Trailing P/E Ratio -0.31
- Forward P/E Ratio -0.31
- P/E Growth -0.31
- Net Income $-7,792,295
Income Statement
Quarterly
Annual
Latest News of EVOK
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
5 Reasons People Have Their Sam's Club Membership Revoked
Sam's Club offers a wide selection at reasonable prices, making it a favorite for shoppers. While memberships aren't typically canceled without reason, certain actions like bounced checks, shoplifting...
By Yahoo! Finance | 2 days ago -
Sigourney Weaver's West End debut as Prospero evokes a storm of past Tempests
Sigourney Weaver will star in a new production of Shakespeare's The Tempest at Theatre Royal Drury Lane....
By The Guardian | 1 week ago -
Trump Team Revokes Election Party Access for Some Journalists
Multiple journalists, including Tara Palmeri from Puck, were barred from covering Donald Trump's election watch event due to critical reporting. Trump campaign revoked credentials for those who wrote ...
By The New York Times | 2 weeks ago
